Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H16BrFN6O4 |
Molecular Weight | 467.249 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CN1N=NC(=N1)C2=CC(=NO2)N3CCC(CC3)OC4=CC(F)=CC=C4Br
InChI
InChIKey=UJEAABFSXKCSGI-UHFFFAOYSA-N
InChI=1S/C17H16BrFN6O4/c18-12-2-1-10(19)7-13(12)28-11-3-5-24(6-4-11)15-8-14(29-22-15)17-20-23-25(21-17)9-16(26)27/h1-2,7-8,11H,3-6,9H2,(H,26,27)
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/21661758Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/22101133
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21661758
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/22101133
Merck was developing MK 8245, an orally active inhibitor of stearoyl CoA desaturase for the treatment of type-2 diabetes mellitus. MK-8245 is a liver-targeting inhibitor of stearoyl-CoA desaturase (SCD) with IC50 of 1 nM for human SCD1 and 3 nM for both rat SCD1 and mouse SCD1, with anti-diabetic and anti-dyslipidemic efficacy. It is in Phase 2 clinical studies for type 2 diabetes mellitus.
Originator
Sources: http://adisinsight.springer.com/drugs/800027623
Curator's Comment: # Merck & Co
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL5555 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21661758 |
1.0 nM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT00790556
50 mg capsules twice daily for 13 days.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21661758
MK-8245 exhibits a significant SCD inhibition in the rat hepatocyte assay which contains functional, active OATPs with IC50 of 68 nM, while being only weakly active in the HepG2 cell assay which is devoid of active OATPs with IC50 of ~1 uM.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1030612-90-8
Created by
admin on Sat Dec 16 07:50:42 GMT 2023 , Edited by admin on Sat Dec 16 07:50:42 GMT 2023
|
PRIMARY | |||
|
DB13024
Created by
admin on Sat Dec 16 07:50:42 GMT 2023 , Edited by admin on Sat Dec 16 07:50:42 GMT 2023
|
PRIMARY | |||
|
DTXSID80145625
Created by
admin on Sat Dec 16 07:50:42 GMT 2023 , Edited by admin on Sat Dec 16 07:50:42 GMT 2023
|
PRIMARY | |||
|
537E7QE8LX
Created by
admin on Sat Dec 16 07:50:42 GMT 2023 , Edited by admin on Sat Dec 16 07:50:42 GMT 2023
|
PRIMARY | |||
|
24988881
Created by
admin on Sat Dec 16 07:50:42 GMT 2023 , Edited by admin on Sat Dec 16 07:50:42 GMT 2023
|
PRIMARY | |||
|
300000041505
Created by
admin on Sat Dec 16 07:50:42 GMT 2023 , Edited by admin on Sat Dec 16 07:50:42 GMT 2023
|
PRIMARY |
ACTIVE MOIETY